The use of cannabis in the treatment of fibromyalgia: An integrative literature review
DOI:
https://doi.org/10.33448/rsd-v14i3.48425Keywords:
Fibromyalgia; Cannabis; Chronic Pain.Abstract
Introduction. Fibromyalgia is defined by nociplastic pain, sleep disturbances, asthenia, headaches, and cognitive symptoms. The endocannabinoid system appears to play a crucial role in the pathophysiology of this condition, and the use of cannabis has emerged as a promising therapeutic alternative. Objective. To provide a descriptive overview of studies investigating the benefits of cannabis use in the treatment of fibromyalgia, including its therapeutic advantages, treatment goals, as well as its cultural and social aspects. Methodology. This study is an integrative review based on a literature search in databases such as PubMed and SciELO, covering the period from 2020 to 2024. A total of 2,851 articles were identified, of which 120 were selected based on inclusion criteria. After a subsequent selection process, 27 articles were included in the final analysis. The selected articles were organized, examined, and subjected to qualitative and content analysis. Results. Studies were categorized into three themes: “symptom improvement,” “adverse effects of cannabis,” and “therapeutic safety.” Determining an optimal therapeutic dose remains challenging due to limited high-quality research. However, most studies reported symptom relief. Safety findings varied depending on the CBD-to-THC ratio. Conclusion. There was a predominance of studies demonstrating the improvement of symptoms and the safety of cannabis and cannabinoids, with a positive correlation between both and the intensity of pain, other symptoms, and pharmacological treatments for fibromyalgia.
References
Aizpurua-Olaizola, O., Elezgarai, I., Rico-Barrio, I., Zarandona, I., Etxebarria, N., & Usobiaga, A. (2017). Targeting the endocannabinoid system: future therapeutic strategies. Drug discovery today, 22(1), 105–110. https://doi.org/10.1016/j.drudis.2016.08.005.
Alves, P. F. S., & Moraes, F. C. (2020). Uso da cannabis no tratamento da fibromialgia. Revista Científica Eletrônica de Ciências Aplicadas da Fait, 2, 1-14.
Andrade, A., Steffens, R. de A. K., Grisard, F., Liz, C. M. de ., Brandt, R., Coimbra, D. R., & Bevilacqua, G. G.. (2023). Strength training in patients with fibromyalgia: a feasibility study. Revista Brasileira de Medicina do Esporte, 29, e176543. https://doi.org/10.1590/1517-869220232901176543.
Argueta, D. A., Ventura, C. M., Kiven, S., Sagi, V., & Gupta, K. (2020). A Balanced Approach for Cannabidiol Use in Chronic Pain. Frontiers in pharmacology, 11, 561. https://doi.org/10.3389/fphar.2020.00561
Arnold, J. C., Nation, T., & McGregor, I. S. (2020). Prescribing medicinal cannabis. Australian prescriber, 43(5), 152–159. https://doi.org/10.18773/austprescr.2020.052
Barros, S. O, Nunes Valadares, M., Oliveira dos Santos , J., Mairesse Ramos , E. H., & Mesquita Couto , F. (2023). Manejo Clínico da Fibromialgia: Terapias Farmacológicas e Não Farmacológicas para Alívio dos Sintomas. Brazilian Journal of Implantology and Health Sciences, 5(5), 5665–5680. https://doi.org/10.36557/2674-8169.2023v5n5p5665-5680.
Bell, A. D., MacCallum, C. A., Margolese, S., Walsh, Z., Wright, P., Daeninck, P. J., Mandarino, E., Lacasse, G., Jagpaul Kaur Deol, Lauren de Freitas, Michelle St Pierre, Belle-Isle, L., Gagnon, M., Bevan, S., Sanchez, T., Arlt, S., Monahan-Ellison, M., O’Hara, J., Boivin, M., & Costiniuk, C. T. (2023). Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions. https://doi.org/10.1089/can.2021.0156.
Berger, A. A., Keefe, J., Winnick, A., Gilbert, E., Eskander, J. P., Yazdi, C., Kaye, A. D., Viswanath, O., & Urits, I. (2020). Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia. Best practice & research. Clinical anaesthesiology, 34(3), 617–631. https://doi.org/10.1016/j.bpa.2020.08.010.
Berl, V., Hurd, Y. L., Lipshutz, B. H., Roggen, M., Mathur, E. J., & Evans, M. (2022). A randomized, triple-blind, comparator-controlled parallel study investigating the pharmacokinetics of cannabidiol and tetrahydrocannabinol in a novel delivery system, solutech, in association with cannabis use history. Cannabis and cannabinoid research, 7(6), 777-789. https://doi.org/10.1089/can.2021.0176
Berwick, R., Barker, C., Goebel, A., & guideline development group (2022). The diagnosis of fibromyalgia syndrome. Clinical medicine (London, England), 22(6), 570–574. https://doi.org/10.7861/clinmed.2022-0402
Bettstetter, H., & Schäfer, A. (2024). Tetrahydrocannabinol (THC) bei Patienten mit Fibromyalgiesyndrom (FMS) : Retrospektive Untersuchung zu Veränderungen von Schmerz, psychometrischen Variablen und Analgetikaverbrauch im Verlauf einer interdisziplinären multimodalen stationären Schmerztherapie (IMST) [Tetrahydrocannabinol (THC) in patients with fibromyalgia syndrome (FMS) : A retrospective study of changes in pain, psychometric variables, and analgesic consumption during inpatient interdisciplinary multimodal pain therapy (IMPT)]. Schmerz (Berlin, Germany), 38(4), 259–266. https://doi.org/10.1007/s00482-023-00727-4
Bilbao, A., & Spanagel, R. (2022). Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC medicine, 20(1), 259. https://doi.org/10.1186/s12916-022-02459-1
Bockmann, E. C., Brito, R., Madeira, L. F., da Silva Sampaio, L., Melo Reis, R. A., França, G. R., & Calaza, K. D. C. (2023). The Role of Cannabinoids in CNS Development: Focus on Proliferation and Cell Death. Cellular and molecular neurobiology, 43(4), 1469–1485. https://doi.org/10.1007/s10571-022-01263-y.
Boehnke, K. F., Gagnier, J. J., Matallana, L., & Williams, D. A. (2021). Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey. The journal of pain, 22(5), 556–566. https://doi.org/10.1016/j.jpain.2020.12.001
Botea, M. O., Lukas Andereggen, Urman, R. D., Luedi, M. M., & Romero, C. S. (2024). Cannabinoids for Acute Pain Management: Approaches and Rationale. Current Pain and Headache Reports. https://doi.org/10.1007/s11916-024-01252-4
Bourke, S. L., Schlag, A. K., O'Sullivan, S. E., Nutt, D. J., & Finn, D. P. (2022). Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research. Pharmacology & therapeutics, 240, 108216. https://doi.org/10.1016/j.pharmthera.2022.108216
Brucki, S. M. D., Adoni, T., Almeida, C. M. O., Andrade, D. C., Anghinah, R., Barbosa, L. M., Bazan, R., Carvalho, A. A. S., Carvalho, W., Christo, P. P., Coletta, M. D., Conforto, A. B., Correa-Neto, Y., Engelhardt, E., França Junior, M. C., Franco, C., VON Glehn, F., Gomes, H. R., Houly, C. G. B., Kaup, A. O., … Prado, G. (2021). Cannabinoids in Neurology - Position paper from Scientific Departments from Brazilian Academy of Neurology. Arquivos de neuro-psiquiatria, 79(4), 354–369. https://doi.org/10.1590/0004-282X-ANP-2020-0432
Cavalcante, Lívia Teixeira Canuto, & Oliveira, Adélia Augusta Souto de. (2020). Métodos de revisão bibliográfica nos estudos científicos. Psicologia em Revista, 26(1), 83-102. https://doi.org/10.5752/P.1678-9563.2020v26n1p82-100
Cásedas, G., Yarza-Sancho, M., & López, V. (2024). Cannabidiol (CBD): A Systematic Review of Clinical and Preclinical Evidence in the Treatment of Pain. Pharmaceuticals (Basel, Switzerland), 17(11), 1438. https://doi.org/10.3390/ph17111438.
Campos, R. M. P., Aguiar, A. F. L., Paes-Colli, Y., Trindade, P. M. P., Ferreira, B. K., Melo Reis, R. A., & Sampaio, L. S. (2021). Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment. Frontiers in physiology, 12, 785176. https://doi.org/10.3389/fphys.2021.785176
Carvalho, J. F., Ribeiro, M. F. L. D. S., & Skare, T. (2024). Cannabis therapy in rheumatological diseases: A systematic review. Northern clinics of Istanbul, 11(4), 361–366. https://doi.org/10.14744/nci.2023.43669.
Chaves, C., Bittencourt, P. C. T., & Pelegrini, A. (2020). Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Pain medicine (Malden, Mass.), 21(10), 2212–2218. https://doi.org/10.1093/pm/pnaa303
Clifford-Faugère, G., Nguena Nguefack, H. L., Godbout-Parent, M., Diallo, M. A., Guénette, L., Pagé, M. G., Choinière, M., Beaudoin, S., Boulanger, A., Pinard, A. M., Lussier, D., De Grandpré, P., Deslauriers, S., & Lacasse, A. (2023). Pain Medications Used by Persons Living With Fibromyalgia: A Comparison Between the Profile of a Quebec Sample and Clinical Practice Guidelines. Canadian journal of pain = Revue canadienne de la douleur, 7(2), 2252037. https://doi.org/10.1080/24740527.2023.2252037.
Dizner-Golab, A., Lisowska, B., & Kosson, D. (2023). Fibromyalgia - etiology, diagnosis and treatment including perioperative management in patients with fibromyalgia. Reumatologia, 61(2), 137–148. https://doi.org/10.5114/reum/163094
Dumont, M. F.; Dias, R. S.; Veiga, R. M. P.; Araujo, I. M. C. S. et al. (2024). Manejo da fibromialgia: uma revisão de literatura. Brazilian Journal of Implantology and Health Sciences, 6(9), 31–40. https://doi.org/10.36557/2674-8169.2024v6n9p31-40
Ergisi, M., Erridge, S., Harris, M., Kawka, M., Nimalan, D., Salazar, O., Loupasaki, K., Ali, R., Holvey, C., Coomber, R., Usmani, A., Sajad, M., Beri, S., Hoare, J., Khan, S. A., Weatherall, M. W., Platt, M., Rucker, J. J., & Sodergren, M. H. (2023). An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry. Cannabis and cannabinoid research, 8(3), 557–566. https://doi.org/10.1089/can.2021.0145.
Esposito, M., & Piazza, L. (2022). Ultrasound-assisted extraction of oil from hempseed (Cannabis sativa L.): Part 1. Journal of the science of food and agriculture, 102(2), 732–739. https://doi.org/10.1002/jsfa.11404
Fitzcharles, M. A., Petzke, F., Tölle, T. R., & Häuser, W. (2021). Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain. Drugs, 81(18), 2103–2116. https://doi.org/10.1007/s40265-021-01602-1.
Freitas, H. R., Isaac, A. R., Malcher-Lopes, R., Diaz, B. L., Trevenzoli, I. H., & Melo Reis, R. A. (2018). Polyunsaturated fatty acids and endocannabinoids in health and disease. Nutritional neuroscience, 21(10), 695–714. https://doi.org/10.1080/1028415X.2017.1347373.
García Rodríguez, D. F., & Abud Mendoza, C. (2020). Physiopathology of fibromyalgia. Fisiopatología de la fibromialgia. Reumatologia clinica, 16(3), 191–194. https://doi.org/10.1016/j.reuma.2020.02.003
Giardina, A., Palmieri, R., Ponticelli, M., Antonelli, C., Carlucci, V., Colangelo, M., Benedetto, N., Di Fazio, A., & Milella, L. (2024). Is a Low Dosage of Medical Cannabis Effective for Treating Pain Related to Fibromyalgia? A Pilot Study and Systematic Review. Journal of clinical medicine, 13(14), 4088. https://doi.org/10.3390/jcm13144088
Giorgi, V., Bongiovanni, S., Atzeni, F., Marotto, D., Salaffi, F., & Sarzi-Puttini, P. (2020). Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study. Clinical and experimental rheumatology, 38 Suppl 123(1), 53–59.
Giossi, R., Carrara, F., Padroni, M., Bilancio, M. C., Mazzari, M., Enisci, S., ... & Fornasari, D. (2022). Systematic review and meta-analysis seem to indicate that cannabinoids for chronic primary pain treatment have limited benefit. Pain and Therapy, 11(4), 1341-1358. https://doi.org/10.1007/s40122-022-00434-5
Gonen, T., & Amital, H. (2020). Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases. Rambam Maimonides medical journal, 11(1), e0007. https://doi.org/10.5041/RMMJ.10389
Hershkovich, O., Hayun, Y., Oscar, N., Shtein, A., & Lotan, R. (2023). The role of cannabis in treatment-resistant fibromyalgia women. Pain practice : the official journal of World Institute of Pain, 23(2), 180–184. https://doi.org/10.1111/papr.13179
Isaac, A. R., Velasco, P. C., Fraga, K. Y. D., Tavares-do-Carmo, M. D. G., Campos, R. M. P., Iannotti, F. A., Verde, R., Martins, D. B. G., Santos, T. A., Ferreira, B. K., Mello, F. G., Di Marzo, V., Andrade-da-Costa, B. L. D. S., & Melo Reis, R. A. (2021). Maternal omega-3 intake differentially affects the endocannabinoid system in the progeny`s neocortex and hippocampus: Impact on synaptic markers. The Journal of nutritional biochemistry, 96, 108782. https://doi.org/10.1016/j.jnutbio.2021.108782
Jacob, M. T. R. J., & Milani, B. J. (2023). Retrograde inhibition of hyperactive central pathways in nociplastic pain. Brjp, 6, 120–125. https://doi.org/10.5935/2595-0118.20230029-en.
Jain, N., & Moorthy, A. (2022). Cannabinoids in rheumatology: Friend, foe or a bystander?. Musculoskeletal care, 20(2), 416–428. https://doi.org/10.1002/msc.1636
Khurshid, H., Qureshi, I. A., Jahan, N., Went, T. R., Sultan, W., Sapkota, A., & Alfonso, M. (2021). A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope?. Cureus, 13(8), e17332. https://doi.org/10.7759/cureus.17332.
Latorraca, C. de O. C., Pacheco, R. L., Martimbianco, A. L. C., Pachito, D. V., & Riera, R. (2018). What do Cochrane systematic reviews say about the use of cannabinoids in clinical practice?. Sao Paulo Medical Journal, 136(5), 472–478. https://doi.org/10.1590/1516-3180.2018.0313210818.
Le, K., Le, R., Nguyen, J., Hua, J., & Munday, S. (2024). The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder. Pain and Therapy. https://doi.org/10.1007/s40122-024-00599-1.
Lopera, V., Restrepo, J. C., & Amariles, P. (2024). Effectiveness and safety of cannabis-based products for medical use in patients with fibromyalgia syndrome: A systematic review. Exploratory research in clinical and social pharmacy, 16, 100524. https://doi.org/10.1016/j.rcsop.2024.100524.
Maffei M. E. (2020). Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies. International journal of molecular sciences, 21(21), 7877. https://doi.org/10.3390/ijms21217877
Manojlović, D., & Kopše, E. I. (2023). The effectiveness of aerobic exercise for pain management in patients with fibromyalgia. European journal of translational myology, 33(3), 11423. https://doi.org/10.4081/ejtm.2023.1142.
Martinez Naya, N., Kelly, J., Corna, G., Golino, M., Polizio, A. H., Abbate, A., Toldo, S., & Mezzaroma, E. (2024). An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects. Molecules (Basel, Switzerland), 29(2), 473. https://doi.org/10.3390/molecules29020473.
Mayorga-Anaya, H. J., Torres-Ortiz, M. P., Flórez-Valencia, D. H., & Gomezese-Ribero, O. F. (2021). Efficacy of cannabinoids in fibromyalgia: a literature review. Colombian Journal of Anestesiology, 49(4), e302. Epub August 25, 2021. https://doi.org/10.5554/22562087.e980.
Mazza M. (2021). Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series. Journal of cannabis research, 3(1), 4. https://doi.org/10.1186/s42238-021-00060-6.
Melo Reis, R. A., Isaac, A. R., Freitas, H. R., de Almeida, M. M., Schuck, P. F., Ferreira, G. C., Andrade-da-Costa, B. L. D. S., & Trevenzoli, I. H. (2021). Quality of Life and a Surveillant Endocannabinoid System. Frontiers in neuroscience, 15, 747229. https://doi.org/10.3389/fnins.2021.747229.
Melo Reis, R. A., et al., (2022). Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice. Frontiers in cellular neuroscience, 16, 917164. https://doi.org/10.3389/fncel.2022.917164.
Mick, G., & Douek, P. (2024). Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts. Pain and therapy, 13(5), 1063–1094. https://doi.org/10.1007/s40122-024-00643-0.
Miranda, M. L. F., Montemezzo, C. P., Zeni, P., & Lutinski, J. A. (2023). Influência da meditação sobre dor, qualidade do sono e qualidade de vida em pessoas com fibromialgia. Brazilian Journal of Implantology and Health Sciences, 5(4), 1926–1947.
https://doi.org/10.36557/2674-8169.2023v5n4p1926-1947.
Mlost, J., Bryk, M., & Starowicz, K. (2020). Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action. International journal of molecular sciences, 21(22), 8870. https://doi.org/10.3390/ijms21228870
Montagner, P., de Salas Quiroga, A., Ferreira, A. S., Duarte da Luz, B. M., Ruppelt, B. M., Schlechta Portella, C. F., Abdala, C. V. M., Tabach, R., Ghelman, R., Blesching, U., Perfeito, J. P. S., & Schveitzer, M. C. (2024). Charting the therapeutic landscape: a comprehensive evidence map on medical cannabis for health outcomes. Frontiers in pharmacology, 15, 1494492. https://doi.org/10.3389/fphar.2024.1494492.
Mozhi, A., & Arumugam, N. (2021). Effects of cognitive behavioral therapy in patients with fibromyalgia: a single blind, randomized controlled study. Revista Pesquisa Em Fisioterapia, 11(1), 41. https://doi.org/10.17267/2238-2704rpf.v11i1.3309.
Nachnani, R., Knehans, A., Vizinhos, J. D., Kocis, P. T., Lee, T., Tegeler, K., Trite, T., Raup-Konsavage, W. M., & Vrana, K. E. (2024). Revisão sistemática das interações droga-droga de delta-9-tetrahidrocanabinol, canabidiol e cannabis. Fronteiras em farmacologia, 15, 1282831. https://doi.org/10.3389/fphar.2024.1282831
O’Sullivan, S. E., Jensen, S. S., Kolli, A. R., Nikolajsen, G. N., Bruun, H. Z., & Hoeng, J. (2024). Strategies to Improve Cannabidiol Bioavailability and Drug Delivery. Pharmaceuticals, 17(2), 244. https://doi.org/10.3390/ph17020244
Pagano, C., Navarra, G., Coppola, L., Avilia, G., Bifulco, M., & Laezza, C. (2022). Cannabinoids: Therapeutic Use in Clinical Practice. International journal of molecular sciences, 23(6), 3344. https://doi.org/10.3390/ijms23063344
Paula, Juliane dos Anjos de. (2021). Uso de psicofármacos no tratamento da fibromialgia: uma revisão sistemática. Journal of Human Growth and Development, 31(2), 336-345. https://doi.org/10.36311/jhgd.v31.12228;
Petzke, F., Tölle, T., Fitzcharles, M. A., & Häuser, W. (2022). Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain. CNS drugs, 36(1), 31–44. https://doi.org/10.1007/s40263-021-00879-w
Raup-Konsavage, W. M., & Vrana, K. E. (2024). Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis. Frontiers in pharmacology, 15, 1282831. https://doi.org/10.3389/fphar.2024.1282831.
Rodrigues, K. da S., da Silva, A. A., da Silva, N. D., & Cavalcanti, Élida B. V. S. (2022). Uma abordagem multidisciplinar não-farmacológica e farmacológica para o tratamento de fibromialgia: uma revisão bibliográfica. Europub Journal of Health Research, 3(4 Edição Especial), 314–319. https://ojs.europubpublications.com/ojs/index.php/ejhr/article/view/215.
Safi, K., Sobieraj, J., Michał Błaszkiewicz, Żyła, J., Salata, B., & Tomasz Dzierżanowski. (2024). Tetrahydrocannabinol and Cannabidiol for Pain Treatment—An Update on the Evidence. Biomedicines, 12(2), 307–307. https://doi.org/10.3390/biomedicines12020307.
Scublinsky, D., Kirmayr , K., Ink, M., Ibelli, F., Graf , C., Lanza, R., González Negri, M. R., & Damin, C. (2020). Uso y prescripción de cannabis medicinal por reumatólogos en Argentina. Revista Argentina De Reumatología, 31(4), 8 - 12. https://doi.org/10.47196/rar.v31i4.381.
Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of business research, 104, 333-339.
Sousa, A. M., Slullitel, A., & Serra, T. S. (2023). Gaps in our knowledge and future research on the endocannabinoid system and the painful phenomenon. Brjp, 6, 97–102. https://doi.org/10.5935/2595-0118.20230025-en.
Sousa, A. M., Slullitel, A., & Serra, T. S. (2023). Gaps in our knowledge and future research on the endocannabinoid system and the painful phenomenon. Brjp, 6, 97–102. https://doi.org/10.5935/2595-0118.20230025-en.
Souza, R. G. de, Trajano, L. A. da S. N., & Fontes, I. A. (2024). Benefícios do treinamento resistido no tratamento de pacientes com fibromialgia: uma revisão de literatura. Revista Pró-UniverSUS, 15(3), 143–147. https://doi.org/10.21727/rpu.v15i3.4539.
Sridharan, S., Erridge, S., Holvey, C., Coomber, R., Holden, W., Rucker, J. J., Platt, M., & Sodergren, M. H. (2024). Comparison of Cannabis-Based Medicinal Product Formulations for Fibromyalgia: A Cohort Study. Journal of pain & palliative care pharmacotherapy, 1–14. Advance online publication. https://doi.org/10.1080/15360288.2024.2414073.
Strand, N. H., Maloney, J., Kraus, M., Wie, C., Turkiewicz, M., Gomez, D. A., Adeleye, O., & Harbell, M. W. (2023). Cannabis for the Treatment of Fibromyalgia: A Systematic Review. Biomedicines, 11(6), 1621. https://doi.org/10.3390/biomedicines11061621
Trevenzoli, I. H. et al., (2021). Quality of Life and a Surveillant Endocannabinoid System. Frontiers in neuroscience, 15, 747229. https://doi.org/10.3389/fnins.2021.747229.
Velayudhan, L., Pisani, S., Dugonjic, M., McGoohan, K., & Bhattacharyya, S. (2024). Eventos adversos causados por canabinoides em adultos de meia-idade e idosos para todas as indicações: uma meta-análise da diferença de taxa de incidência. Idade e envelhecimento, 53(11), afae261. https://doi.org/10.1093/ageing/afae261.
Wang, C., Erridge, S., Holvey, C., Coomber, R., Usmani, A., Sajad, M., Guru, R., Holden, W., Rucker, J. J., Platt, M. W., & Sodergren, M. H. (2023). Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry. Brain and behavior, 13(7), e3072. https://doi.org/10.1002/brb3.3072.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Kauan Costa Teles Lopes; Alcides Rocha Pires Filho; Breno Oliveira da Silva; Isaías Prado Meire; Matheus Santos Marques
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
